HARROW, INC. — Director's Dealing 2016

Jun 14, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Imprimis Pharmaceuticals, Inc. (IMMY)
CIK: 0001360214
Period of Report: 2016-06-10

Reporting Person: LINDSTROM RICHARD L MD (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-06-10	RSU	$0	A	12690	Acquired	2017-06-10	Common Stock (12690)	Direct

Footnotes

F1: Award of Restricted Stock Units vests quarterly in equal installments over a one year period following the date of grant. The shares underlying such Restricted Stock Units will not be delivered to the Reporting Person and may not be transferred or sold until the termination of service.

F2: The Restricted Stock Units were received as a compensatory award for no consideration.